Background. Altered cerebral circulation, as reported during normal pregnancy, and in patients with pre-eclampsia, can be associated with changes in cerebral vascular reactivity and/ or cerebral autoregulation. The aim of our study was to perform a comparative assessment of cerebral haemodynamics, including vascular reactivity and autoregulation, in pre-eclamptic patients, healthy pregnant women, and healthy non-pregnant women.
Pregnancy induces widespread changes in the cardiovascular system. 1 2 Cerebral blood¯ow has been shown to be increased by up to 25% in the ®rst trimester, 3 but it reduces with increasing gestational age and, in the third trimester, it remains at up to 15% more than that in the nonpregnant state. 4 5 Pre-eclampsia has been shown to be associated with an increased middle cerebral artery blood ow velocity (MCAFV) and abnormal transcranial Doppler (TCD) ®ndings compared with the healthy pregnant state. 6 This increase in MCAFV is thought to be secondary to vasospasm and cerebral oedema. 6 7 During induction of anaesthesia, increases in MCAFV associated with increases in arterial pressure in pre-eclamptic patients have been reported to be signi®cantly more than the increases seen in patients with a healthy pregnancy. 8 Changes in vascular tone can affect cerebral perfusion pressure (CPP) by altering the critical closing pressure (CrCP) of cerebral arterioles. pregnancy and pre-eclampsia, 3±5 the effects of pregnancy with or without pre-eclampsia on cerebral vascular reactivity, cerebral autoregulation, CPP, and CrCP have not been well documented.
Non-invasive assessment of cerebral haemodynamics using TCD ultrasonography has recently gained importance. Essentially, TCD measures¯ow velocity in the insonated vessel and the changes in¯ow velocity can be taken to re¯ect the changes in blood¯ow, assuming that the diameter of the insonated vessel remains constant. As TCD is easy to use and gives reproducible measurements, it has become a widely accepted method of assessing the cerebrovascular reactivity to carbon dioxide (CRCO 2 ), cerebral autoregulation, estimated (e)CPP, and CrCP. 7 9±15 In patients with neurological disorders, impairment in both cerebral autoregulation and cerebral vascular reactivity has been shown to predict poor neurological outcome. 15±17 Knowledge of the effects of normal pregnancy and pre-eclampsia on cerebral haemodynamics is essential for appropriate management of these patients undergoing anaesthesia or in labour, particularly when vasoactive medications are administered.
The aim of the present study was to make a comparative assessment of cerebral haemodynamic variables such as cerebral autoregulation, CRCO 2 , eCPP, and CrCP, using TCD in pre-eclamptic patients, healthy pregnant women, and healthy non-pregnant women.
Materials and methods
After obtaining hospital ethics committee approval and written informed consent, we recruited 30 pre-eclamptic women, in the third trimester of pregnancy, from the obstetric unit. Pre-eclampsia was de®ned as an arterial pressure greater than 140/90 mm Hg on two separate occasions, with associated proteinuria (>2+ on dipstick and/ or >0.3 g litre ±1 on a 24-h collection), occurring after the 20th week of gestation. Healthy pregnant (third trimester; n=30) and non-pregnant women, matched for age and height to the pre-eclamptic women, were also recruited. Women with evidence of neurological disorder, recent head injury, pre-existing vascular disease, diabetes, renal disease, headache, and current vasoactive medication were excluded from the study.
Assessment of cerebrovascular haemodynamics was performed as soon as possible after the diagnosis of preeclampsia. Patients' age, height, body mass index (BMI), gestational age (in pregnant patients), and arterial pressure were recorded. Before recruitment into the study, all the patients were fully assessed by obstetricians and those with severe pre-eclampsia (diastolic arterial pressure greater than 110 mm Hg and/or evidence of hyper-re¯exia) were admitted immediately for anti-hypertensive therapy and/or induction of labour, and could not therefore be included in the study. The pre-eclamptic patients who were admitted to the study underwent carotid ultrasound scan to exclude any signi®cant carotid artery disease.
All pre-eclamptic subjects were followed-up at 6 and/or 12 weeks post-partum to ensure that their arterial pressure had returned to normal levels, proteinuria had cleared, and that they had not suffered any neurological problems at any time during their stay in hospital or thereafter.
Study set-up
All subjects were studied in the supine position. The pregnant women were positioned with 15°left-lateral tilt to minimize any aortocaval compression. The left middle carotid artery (MCA) was identi®ed using a 2 MHz-pulsed TCD probe (SciMed PCDop 842), and the position of the probe was ®xed with a headband to ensure a constant angle of insonation throughout the period of the study. TCD measurements were recorded onto digital audiotape for subsequent analysis using speci®c software (SciMed UK). Following application of a nose clip, constant end-tidal carbon dioxide (E¢ CO 2 ) monitoring was instituted via a mouthpiece connected to a Datex Capnomac monitor. The arterial pressure was measured at 1-min intervals with a non-invasive arterial pressure monitor (Dynamap) for the duration of the test. Further monitoring included heart rate and oxygen saturation measurements using pulse oximetry.
Following a period of acclimatization to the study apparatus, each subject's baseline heart rate, arterial pressure, oxygen saturation, E¢ CO 2 , and MCAFV were recorded.
TCD data
Cerebral autoregulation was assessed by the transient hyperaemic response (THR) test. 12 13 This involved a 10-s compression of the ipsilateral common carotid artery (CCA) followed by sudden release of the compression, leading to hyperaemic¯ow in the MCA. Criteria for acceptance of a THR test were: (1) a sudden and maximal decrease in¯ow velocity at onset of the compression; (2) stable heart rate for the period of the compression; (3) steady TCD signal for the duration of the compression; and (4) absence of¯ow transients following release of the compression.
Two indices were used to analyse the THR test to assess autoregulation: the transient hyperaemic response ratio (THRR); 11 and the strength of autoregulation (SA). 12 13 To calculate these indices, three MCAFV waveforms were selected from the recordings during the THR test ( Fig. 1): (1) the MCA waveform immediately before compression, F1; (2) the ®rst waveform following compression, F2; and (3) the waveform immediately following release of compression, F3. The time-averaged mean of the outer envelope of the¯ow velocity pro®le was used for performing the analysis (Fig. 1) . THRR was calculated as:
SA was calculated as:
where P2 is the greater value of either the estimated arterial pressure in the MCA at the onset of CCA compression, as calculated by P2=MAPQF2/F1, or 60 mm Hg (the assumed lower limit of autoregulation). Details of the derivation of these formulae have been published elswhere. 12 13 The compression ratio (CR), a measure of the magnitude of decrease in¯ow velocity during the compression, was calculated using the formula: 11 CR%=(F1±F2)Q(100/F1) CRCO 2 was assessed by recording the MCAFV during induced hypocapnia (voluntary hyperventilation to an E¢ CO 2 of 1 kPa below baseline), and hypercapnia (addition of carbon dioxide to the inspired gases (oxygen-enriched air) to achieve an E¢ CO 2 of 1 kPa above baseline). CRCO 2 was calculated as per cent change in MCAFV per kPa change in E¢ CO 2 .
The eCPP and CrCP were calculated using the method described by Belfort and colleagues. 
Statistics
We calculated that 30 patients would be required in each of the three groups to detect a 20% difference in the SA across the groups with 90% power at alpha=0.05, assuming the coef®cient of variation of SA to be approximately 10%. The coef®cient of variation for SA was assumed because of lack of previous data in pregnant women.
All data sets were checked for normality of distribution using the Anderson±Darling test. For comparisons between groups, ANOVA with Tukey's test (for pairwise comparison) was used for parametric data, and Kruskal±Wallis test was used for non-parametric data. P<0.05 was used to denote statistical signi®cance. Minitab Release 13.3 was used for all statistical analyses.
Results
Thirty-®ve women with pre-eclampsia were enrolled into the study. Two were not included because of obstetric intervention before completion was possible, two because we were unable to identify a suitable MCA signal, and one because we were unable to perform a satisfactory THR test. None of the pre-eclamptic patients had a carotid artery atheromatous plaque.
The characteristics of the three groups of women included in the study are shown in Table 1 . The groups were comparable for distribution of age and height; parity and gestation in healthy pregnant patients were similar to preeclamptics. Compared with non-pregnant subjects, the BMI in pre-eclamptic patients was signi®cantly higher (P<0.05).
Baseline values for arterial pressure and E¢ CO 2 for the three groups are shown in Table 2 . The systolic, diastolic, and mean arterial pressures (MAP) were signi®cantly higher in the pre-eclamptic group (P<0.05) as compared with the healthy pregnant and non-pregnant control groups. The baseline E¢ CO 2 levels in the pre-eclamptic and healthy Cerebral haemodynamics in pre-eclampsia pregnant groups were signi®cantly lower than in the nonpregnant group (P<0.05).
The values of the cerebral haemodynamic variables are given in Table 3 . Baseline MCAFV was signi®cantly lower (P<0.05) in the healthy pregnant group compared with the pre-eclamptic and non-pregnant groups. There were no signi®cant differences between the three groups for CR, THRR, SA, or CRCO 2 . eCPP was signi®cantly higher (P<0.05) in the pre-eclamptic and pregnant groups as compared with the non-pregnant control group. The CrCP was signi®cantly lower in the healthy pregnant control group than the other two groups.
Discussion
We have shown that normal pregnancy is associated with a lower MCAFV as compared with non-pregnant women. However, MCAFV in pre-eclampsia is similar to that in non-pregnant women. The eCPP is higher in healthy pregnant women, as compared with non-pregnant women, and is maintained at this higher level during pre-eclampsia.
Changes in MCAFV
The effects of pregnancy and/or pre-eclampsia on MCAFV have been studied by other investigators. Ikeda and colleagues 3 5 found little change in mean MCAFV during the ®rst two trimesters but reduced values in the third trimester. Williams and Wilson 4 showed that MCAFV fell signi®cantly with advancing gestational age. In another study, Williams and Wilson 18 used TCD to assess cerebral haemodynamics in 17 non-pregnant women, 17 normotensive pregnant women, 20 pregnant women with pre-existing hypertension, and 21 pre-eclamptic women. The pregnant women were all in their third trimester. There was no difference in mean MCAFV in healthy pregnancy compared with non-pregnant women and a small, but non-signi®cant, increase in mean MCAFV in the hypertensive and preeclamptic women. Demarin and colleagues 6 studied preeclamptic women before and after delivery and found a progressive increase in MCAFV during late pregnancy. Ohno and colleagues 19 compared MCAFV in 35 healthy pregnant and 17 pre-eclamptic women. In this study, the mean MCAFV was signi®cantly higher in the pre-eclamptic group. It has been suggested that these increases in MCAFV are because of a degree of vasospasm. The differences between the ®ndings of various studies with regards to the changes in MCAFV in pre-eclampsia might be explained by the differences in the severity of pre-eclampsia between the studies. Some investigators have reported increased MCAFV in symptomatic, compared with asymptomatic pre-eclamptics. 6 20 21 In the present study, all our patients in the pre-eclampsia group were asymptomatic. We found that the values of MCAFV in pre-eclampsia, although similar to those in the non-pregnant group, were signi®cantly higher than those seen in healthy pregnancy. These ®ndings are in agreement with some of the previous reports.
3 5 6 19 Overall, it would appear that MCAFV falls with advancing gestational age. An increase in late pregnancy to a level equal to, or greater than, normal non-pregnant velocities is suggestive of preeclampsia and probable underlying vasospasm.
Cerebral autoregulation and carbon dioxide reactivity
As far as we are aware, there are no previously reported studies using TCD, which have looked speci®cally at the effects of pregnancy and/or pre-eclampsia upon cerebral autoregulation or CRCO 2 . It has been generally assumed that cerebral autoregulation remains intact during healthy pregnancy as the increase in cerebral blood¯ow is limited despite the raised cardiac output. 1 With respect to preeclampsia, some investigators have suggested that the endothelial dysfunction seen in the pre-eclampsia/eclampsia syndrome may alter cerebral haemodynamics. 22 Our study con®rms that cerebral autoregulation remains intact in healthy pregnancy, as we found no signi®cant differences in THRR, SA, or CRCO 2 between the nonpregnant and healthy pregnant groups. In addition, perhaps surprisingly, we found no difference in these variables in patients with pre-eclampsia. This may be because all our pre-eclamptic patients were asymptomatic, and therefore, can be supposed to have had only mild disease. None of the pre-eclamptic women we studied went on to suffer an eclamptic seizure. Our study procedure required a carotid ultrasound scan in the department of radiology before investigation of the patient's cerebral haemodynamics. We were therefore unable to investigate severe pre-eclamptics as they were either con®ned to the labour suite, or underwent urgent Caesarean section. The carotid ultrasound scan in pre-eclamptic patients was performed to rule out the presence of any atheromatous plaques in the internal carotid artery, which in theory, could be dislodged during carotid compression for the THR test. The risk of developing atheromatous disease in pre-eclampsia has not been reported. We decided to screen pre-eclamptic patients as a matter of precaution because hypertension is one of the risk factors for developing atheromatous disease. Patients from other groups were not screened because they did not have any of the risk factors associated with atheromatous disease.
CPP and CrCP
Some studies have investigated eCPP in pre-eclamptic patients. Williams and Wilson 18 found that mean eCPP was signi®cantly lower in non-pregnant women compared with both healthy pregnant and (mild) pre-eclamptic women. Belfort and colleagues 22 suggested that the brain can bè normally perfused, under-perfused or over-perfused' in pre-eclampsia. In a different study, Belfort and colleagues 20 also found that increasing severity of headache was associated with increasing eCPP.
We found a lower eCPP in non-pregnant women compared with healthy pregnant and pre-eclamptic women. There was no difference between healthy pregnancy and pre-eclampsia. These ®ndings are similar to those of Williams and Wilson, 18 although the absolute values of eCPP in our study are different. Previously reported results by Belfort and colleagues, 20 would suggest that the majority of the pre-eclamptics in our study had mild disease. The interpretation of the results of our study in conjunction with the previous studies, 18 20±22 would suggest that pregnancy leads to an increase in eCPP, with further increases in symptomatic, but not severe pre-eclampsia.
The only previously published data on cerebral CrCP in pregnancy comes from Belfort and colleagues 7 in a study of the effects of nimodipine and magnesium on eCPP in preeclampsia. They found that magnesium increased, and nimodipine reduced CrCP. Our data suggest that CrCP is reduced in the latter stages of healthy pregnancy, compared with non-pregnant women. This results in increased eCPP in healthy pregnancy despite an unchanged MAP. However, in pre-eclampsia the CrCP increases, probably as a result of increased vascular tone, so that despite a signi®cant increase in MAP, the level of eCPP remains unchanged.
What is the clinical signi®cance of our results? As cerebral autoregulation and CRCO 2 are preserved in healthy pregnancy and in asymptomatic pre-eclampsia, these groups of patients should be able to tolerate moderate changes in E¢ CO 2 or MAP under anaesthesia. Healthy pregnancy is associated with increased eCPP, which is a result of a decrease in downstream CrCP. In pre-eclampsia, an increase in MAP is also associated with an increase in downstream pressure, therefore CPP is maintained. The hypotensive agents used in pre-eclampsia may affect CrCP in varying manner. It would be logical to use agents that affect MAP and CrCP in a similar fashion so the CPP is maintained. Therapies that reduce MAP but not CrCP will reduce cerebral perfusion. Further work needs to be done in this ®eld, both to study the effects of severe/symptomatic pre-eclampsia upon the cerebral circulation, and the effects of the various anti-hypertensive drugs used in its treatment.
